The role of metallothionein, glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents
- PMID: 8424817
- DOI: 10.1016/0006-2952(93)90399-h
The role of metallothionein, glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents
Abstract
The glutathione contents, glutathione S-transferase activities and metallothionein contents have been measured in a series of L1210 cell lines which show decreased sensitivities to platinum drugs. Resistance to cisplatinum cisDDP, cis-diamminedichloroplatinum (II)] and chip [ioproplatin, cisdichloro-bis-isopropylamine-trans dihydroxy platinum IV] was found to correlate with glutathione levels but not metallothionein. Conversely, resistance to tetraplatin was found to be correlated with metallothionein but not glutathione levels. However, depletion of glutathione by buthionine 1-sulphoximine sensitizes all cell lines to the effects of cisDDP, chip and tetraplatin [d,1-trans-tetrachloro-1,2-diamino-cyclohexanplatinum (IV)]. Inhibition of DNA repair by aphidicholin or caffeine also partially restored sensitivity to these platinum drugs. These results indicate the complexity of the changes occurring upon the development of drug resistance.
Similar articles
-
In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.Br J Cancer. 1993 Aug;68(2):240-50. doi: 10.1038/bjc.1993.322. Br J Cancer. 1993. PMID: 8347478 Free PMC article.
-
Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II).Cancer Chemother Pharmacol. 1987;20(2):96-100. doi: 10.1007/BF00253961. Cancer Chemother Pharmacol. 1987. PMID: 3664938
-
The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.Neoplasma. 1992;39(3):189-95. Neoplasma. 1992. PMID: 1528325
-
Mechanisms of acquired resistance to cisplatin.Cancer Treat Res. 1994;73:217-48. doi: 10.1007/978-1-4615-2632-2_11. Cancer Treat Res. 1994. PMID: 7710906 Review. No abstract available.
-
Mechanisms of resistance to cisplatin.Cancer Treat Res. 1991;57:233-49. doi: 10.1007/978-1-4615-3872-1_11. Cancer Treat Res. 1991. PMID: 1686719 Review.
Cited by
-
In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.Br J Cancer. 1993 Aug;68(2):240-50. doi: 10.1038/bjc.1993.322. Br J Cancer. 1993. PMID: 8347478 Free PMC article.
-
Lipid peroxidative damage on Cisplatin exposure and alterations in antioxidant defense system in rat kidneys: a possible protective effect of selenium.Int J Mol Sci. 2012;13(2):1790-1803. doi: 10.3390/ijms13021790. Epub 2012 Feb 8. Int J Mol Sci. 2012. PMID: 22408424 Free PMC article.
-
Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells.Jpn J Cancer Res. 1995 Jan;86(1):88-94. doi: 10.1111/j.1349-7006.1995.tb02992.x. Jpn J Cancer Res. 1995. PMID: 7737915 Free PMC article.
-
Intracellular glutathione and cytotoxicity of platinum complexes.Cancer Chemother Pharmacol. 1995;36(4):271-8. doi: 10.1007/BF00689042. Cancer Chemother Pharmacol. 1995. PMID: 7628045
-
Apoptosis-inducing ability of silver(I) cyanide-phosphines useful for anti-cancer studies.Cytotechnology. 2017 Aug;69(4):591-600. doi: 10.1007/s10616-017-0070-y. Epub 2017 Feb 10. Cytotechnology. 2017. PMID: 28188415 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous